Collection
Emerging Leaders in Cancer Chemotherapy and Pharmacology
- Submission status
- Open
- Open for submission from
- 15 September 2022
- Submission deadline
- Ongoing
The Emerging Leaders collection welcomes and recognizes new talent in the oncology field. This collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers. It serves as a platform to showcase Emerging Leaders and their exciting work in the cancer chemotherapy and pharmacology field.
Articles (3 in this collection)
-
-
Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients
Authors (first, second and last of 12)
- Stefanie L. Groenland
- J. M. Janssen
- N. Steeghs
- Content type: Original Article
- Published: 22 March 2023
- Pages: 447 - 456
-
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial
Authors (first, second and last of 16)
- Nikki de Rouw
- René J. Boosman
- Rob ter Heine
- Content type: Original Article
- Published: 21 November 2022
- Pages: 33 - 42